Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Endocrinol Invest ; 36(1): 50-4, 2013 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-23211454

RESUMEN

BACKGROUND: Hirsutism is defined as the presence of excessive terminal hair in androgen-dependent areas of a woman's body. Regarding this it has been suggested that Lavender and Tea tree oils may have antiandrogenic activities. AIM: To evaluate therapy based on Lavender and Tea tree oils in women suffering from mild idiopathic hirsutism (IH). SUBJECTS AND METHODS: A prospective, open-label, placebo- controlled, randomized study was performed: women affected by mild IH were randomly assigned to receive oil spray containing Lavender and Tea tree oils (group T) (no. = 12) or placebo (group P) (no. = 12) twice a day for 3 months in areas affected by hirsutism. Evaluation of hirsutism was carried out at baseline and after 3 months by Ferriman-Gallwey score and by measuring hair diameter taken from some body areas. A hematological and hormonal evaluation was carried out at baseline and after 3 months. RESULTS: No significant variations were found in any of the hormones studied in groups T and P between baseline and after 3 months. A statistically significant decrease of hirsutism total score and of hair diameter was found in group T, while no statistically significant difference in these two parameters was observed in group P; in group T percentual reduction of hair diameter was significantly greater than in group P. CONCLUSIONS: Lavender and Tea tree oils applied locally on skin could be effective in reducing mild IH; this treatment could represent a safe, economic and practical instrument in the cure of this disease.


Asunto(s)
Antagonistas de Andrógenos/uso terapéutico , Antiinfecciosos Locales/uso terapéutico , Hirsutismo/tratamiento farmacológico , Lavandula/química , Fitoterapia , Aceite de Árbol de Té/uso terapéutico , Adulto , Femenino , Humanos , Estudios Prospectivos , Resultado del Tratamiento
2.
Drugs Exp Clin Res ; 24(1): 51-5, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-9604148

RESUMEN

In view of the increasing interest in the biological activity of resveratrol, one of the components of red wine which is considered to be one of the main ingredients responsible for the beneficial effect of wine on human health, we have studied plasma kinetics and tissue bioavailability of this compound after red wine oral administration in rats. Plasma pharmacokinetics after oral administration of resveratrol could be described by an open one- or two-compartment model. Tissue concentrations show a significant cardiac bioavailability, and a strong affinity for the liver and kidneys.


Asunto(s)
Extractos Vegetales/farmacocinética , Estilbenos/química , Vino , Administración Oral , Animales , Disponibilidad Biológica , Estudios de Evaluación como Asunto , Masculino , Tasa de Depuración Metabólica , Extractos Vegetales/sangre , Ratas , Ratas Wistar , Resveratrol , Sesquiterpenos , Terpenos , Fitoalexinas
3.
Drugs Exp Clin Res ; 19(2): 65-8, 1993.
Artículo en Inglés | MEDLINE | ID: mdl-8223144

RESUMEN

This investigation was conducted to ascertain whether administration of L-carnitine and coenzyme Q10 could protect from the experimentally-induced hepatic lipid infiltration and glutathione content decrease in rats exposed to hyperbaric oxygen and prolonged alcohol administration. The results indicate that administration of L-carnitine and coenzyme Q10 in association reduces damage induced by chronic alcohol poisoning and hyperbaric oxygen. This protective action is more marked when L-carnitine and coenzyme Q10 are administered together. The combined complementary biochemical activity of these two compounds is discussed.


Asunto(s)
Carnitina/farmacología , Etanol/toxicidad , Oxigenoterapia Hiperbárica , Hígado/metabolismo , Triglicéridos/metabolismo , Ubiquinona/farmacología , Animales , Enfermedad Hepática Inducida por Sustancias y Drogas/metabolismo , Sinergismo Farmacológico , Glutatión/metabolismo , Peróxidos Lipídicos/metabolismo , Hígado/efectos de los fármacos , Masculino , Ratas , Ratas Wistar
4.
Int J Tissue React ; 12(3): 193-6, 1990.
Artículo en Inglés | MEDLINE | ID: mdl-2276900

RESUMEN

The comparative biochemical activities of coenzyme Q10 and carnitine can explain the protective synergistic effect of combination of these two substances in preventing the hyperbaric oxygen toxicity in mice. Both convulsions and mortality percentages are more significantly reduced in treated animals with these two substances in combination rather than separately.


Asunto(s)
Carnitina/uso terapéutico , Oxigenoterapia Hiperbárica/efectos adversos , Ubiquinona/uso terapéutico , Animales , Coenzimas , Sinergismo Farmacológico , Quimioterapia Combinada , Masculino , Ratones , Convulsiones/etiología , Convulsiones/prevención & control
5.
Int J Tissue React ; 12(3): 197-201, 1990.
Artículo en Inglés | MEDLINE | ID: mdl-2276901

RESUMEN

Exogenous L-carnitine and coenzyme Q are used to protect the heart against anthracycline damage and to enhance energy metabolism in the heart and in the muscle. Though their metabolic function is well known and their effects on anthracycline damage have been largely studied, their combined action has not been investigated. Therefore we have used partially CoQ-depleted bovine mitochondria to evaluate the synergic action of CoQ and carnitine on palmitoylCoA oxidation, as an experimental model in which either CoQ or L-carnitine may be the limiting factor in the oxidation of activated fatty acids. The protective effect exerted by the combined use of L-carnitine and CoQ against damage by the anthracycline derivative doxorubicin has been compared to the protection exerted by each compound alone. The effect was evaluated by assessing oxygen consumption and 14C-leucine incorporation in rat heart slices. The results obtained suggest that the administration of an association of L-carnitine and CoQ exerts a stronger protection against anthracycline damage and induces a greater utilization of fatty acids as compared to the effects of each compound alone.


Asunto(s)
Antibióticos Antineoplásicos/antagonistas & inhibidores , Carnitina/farmacología , Ácidos Grasos/metabolismo , Mitocondrias Cardíacas/efectos de los fármacos , Ubiquinona/farmacología , Animales , Radioisótopos de Carbono , Bovinos , Doxorrubicina/antagonistas & inhibidores , Sinergismo Farmacológico , Técnicas In Vitro , Leucina/metabolismo , Oxidación-Reducción , Oxidorreductasas/metabolismo , Consumo de Oxígeno/efectos de los fármacos
6.
Drugs Exp Clin Res ; 16(10): 527-30, 1990.
Artículo en Inglés | MEDLINE | ID: mdl-2100735

RESUMEN

The protective effect of propionyl-L-carnitine against hyperbaric oxygen toxicity was studied by in vivo experiments on mice. The treatment reduced both the percentage of animals with convulsions and the death rate. Tissue signs of toxicity and pulmonary weight increase were less marked in treated animals than in controls. Results may indicate that propionyl-L-carnitine needs to build up to critical levels in cells and mitochondria before its metabolic effects can be fully felt.


Asunto(s)
Carnitina/análogos & derivados , Oxigenoterapia Hiperbárica/efectos adversos , Animales , Carnitina/uso terapéutico , Enfermedades Pulmonares/etiología , Enfermedades Pulmonares/prevención & control , Masculino , Ratones , Convulsiones/etiología , Convulsiones/prevención & control
7.
Int J Tissue React ; 12(6): 359-62, 1990.
Artículo en Inglés | MEDLINE | ID: mdl-2102900

RESUMEN

The ethanol-induced increased synthesis of fatty acids in the liver is enhanced by hyperbaric oxygen exposure. Both lipid peroxidation and glutathione depletion are involved in these hepatic alterations. Coenzyme A can intervene in these mechanisms. The administration of CoA prevents hepatic lipid infiltration and the glutathione reduction induced in the rats by ethanol and hyperbaric oxygen exposure.


Asunto(s)
Coenzima A/farmacología , Etanol/toxicidad , Oxigenoterapia Hiperbárica , Hígado/metabolismo , Triglicéridos/metabolismo , Animales , Hígado/efectos de los fármacos , Cirrosis Hepática Alcohólica/prevención & control , Masculino , Enfermedades Metabólicas/inducido químicamente , Enfermedades Metabólicas/prevención & control , Ratas , Ratas Endogámicas , Compuestos de Sulfhidrilo/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA